DEF 14AThe Ballot
Enliven Therapeutics, Inc. files DEF 14A
Filed Apr 27, 2026 · 2mo ago · Accession 0001193125-26-182045
Plain English
Proxy statement — executive pay, board nominees, and shareholder votes.
Read the source below for the full document.
Filing details
- Company
- Enliven Therapeutics, Inc.
- Ticker
- ELVN
- CIK
- 1672619
- Form type
- DEF 14A
- Filing date
- Apr 27, 2026
- Report date
- Jun 9, 2026
- Document
- d948512ddef14a.htm
- Size
- 2.1 MB